http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007129318-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a74c00b24168e4ea8cd82826d42909c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
filingDate 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ab01820668c5ca494cf88fb01ee536
publicationDate 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2007129318-A1
titleOfInvention Antisense oligonucleotide having anticancerous activity
abstract An antisense oligonucleotide having anti-carcinogenicity, for example, an inhibitory action on growth of cancer cells and a therapeutic or prophylactic action on cancer and the like, as well as an inhibitor of cancer cell growth and a therapeutic or prophylactic agent for cancer, which comprise the antisense oligonucleotide are provided. An antisense oligonucleotide to a nucleotide sequence of positions 47 to 51 of 7SL RNA of the signal recognition particle (SRP), an inhibitor of cancer cell growth comprising the antisense oligonucleotide, and a therapeutic or prophylactic agent for cancer comprising the antisense oligonucleotide.
priorityDate 2004-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5985558-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003232443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5827705-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6566514-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6130207-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128256620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226446069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128133954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129119613

Total number of triples: 43.